Craft

Opko Health

Stock Price

$1.6

2024-10-29

Market Capitalization

$1.1 B

2024-10-29

Revenue

$606.9 M

FY, 2025

Opko Health Summary

Company Summary

Overview
OPKO Health is a multi-national pharmaceutical and diagnostics company that aims to establish industry-leading positions in large and rapidly growing medical markets by leveraging its discovery, development, and commercialization expertise and its novel and proprietary technologies. The Company intends to leverage its global commercialization expertise to pursue acquisitions of commercial businesses that will both drive growth and provide geographically diverse sales and distribution opportunities.
Type
Public
Status
Active
Founded
2007
HQ
Miami, FL, US | view all locations
Website
http://www.opko.com
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Phil Frost

    Phil Frost, CEO and Chairman

    • Jane Hsiao

      Jane Hsiao, CTO and Vice Chairman

    • Steve Rubin

      Steve Rubin, Executive Vice President, Administration

      • Adam Logal

        Adam Logal, Senior Vice President and CFO

        LocationsView all

        2 locations detected

        • Miami, FL HQ

          United States

          4400 Biscayne Blvd

        • Woburn, MA

          United States

          Woburn, MA, USA

        Opko Health Financials

        Summary Financials

        Revenue (Q1, 2026)
        $124.2M
        Gross profit (Q1, 2026)
        $45.8M
        Net income (Q1, 2026)
        ($54.8M)
        Cash (Q1, 2026)
        $331.9M
        EBIT (Q1, 2026)
        ($51.0M)
        Enterprise value
        $919.1M

        Footer menu